Breaking News Instant updates and real-time market news.

AMRX

Amneal Pharmaceuticals

$3.45

-0.145 (-4.04%)

16:13
09/11/19
09/11
16:13
09/11/19
16:13

Amneal Pharmaceuticals initiated with a Sell at Guggenheim

Guggenheim analyst Dana Flanders started Amneal Pharmaceuticals with a Sell rating and $2.50 price target.

  • 06

    Nov

AMRX Amneal Pharmaceuticals
$3.45

-0.145 (-4.04%)

07/29/19
CANT
07/29/19
NO CHANGE
Target $26
CANT
Neutral
Vivitrol settlement removes overhang on Alkermes stock, says Cantor Fitzgerald
Cantor Fitzgerald analyst Brandon Folkes believes the announcement that Alkermes (ALKS) and Amneal Pharmaceuticals (AMRX) have settled their IPR challenge over Vivitrol removes one of the overhangs on Alkermes stock. The analyst views the settlement, allowing Amneal entry in 2028, as a positive for Alkermes given the fact that about 64% of instituted IPR challenges find that all claims are unpatentable. That said, he believes that consensus estimates for Vivitrol had assumed an Alkermes win in the IPR challenge given the strong growth in consensus Vivitrol sales through 2024, and believes estimates leave little room for upward earnings revisions. Folkes reiterates a Neutral rating and $26 price target on Alkermes' shares.
07/30/19
HCWC
07/30/19
NO CHANGE
Target $28
HCWC
Neutral
Alkermes settlement close to best-case scenario, says H.C. Wainwright
H.C. Wainwright analyst Douglas Tsao says Alkermes' (ALKS) settlement and license agreement with Amneal Pharmaceuticals (AMRX) provides a "measure of needed visibility." There was some investor nervousness coming into the hearing and this settlement "represents close to a best-case scenario for Alkermes," Tsao tells investors in a research note. Vivitrol's growth has slowed but 12% volume growth in Q2 indicates the franchise can continue to be a contributor for the foreseeable future, adds the analyst. Tsao thinks the bull thesis for Alkermes hinges largely on the prospects for ALKS-4230. The update that patients on ALKS-4230 appear to avoid capillary leak syndrome, which has limited the utility of IL-2 therapies in the past, is important, according to Tsao. He keeps a Neutral rating on Alkermes with a $28 price target.
07/30/19
PIPR
07/30/19
NO CHANGE
PIPR
Neutral
Piper says Alkermes scores 'back-to-back wins' with settlement, Biogen data
Piper Jaffray analyst Danielle Brill said Alkermes (ALKS) has scored "back-to-back wins" with its announcement yesterday that it settled the ongoing Vivitrol patent dispute with Amneal (AMRX) and the news this morning that BIIB098 showed a statistically significant improvement on GI tolerability versus Tecfidera in a head-to-head Phase 3 trial. She still questions how meaningful the improvement in GI tolerability actually is, but thinks the drug may become a priority for partner Biogen (BIIB), Brill tells investors. The analyst, who views the news of the last two days as net positive for Alkermes, maintains her concerns about long-term value creation and the company's "dry pipeline," she said. Brill keeps a Neutral rating on Alkermes shares.
08/06/19
RHCO
08/06/19
NO CHANGE
Target $5
RHCO
Buy
Amneal Pharmaceuticals price target lowered to $5 from $9 at SunTrust
SunTrust analyst Gregg Gilbert lowered his price target on Amneal Pharmaceuticals to $5 after its Q2 earnings miss and announced departures of "industry veterans" Chairman and CEO, saying his updated model now anticipates lower revenue and gross margins for the company's generics business. The analyst also maintains a Buy rating on Amneal Pharmaceuticals but recommends that investors take a wait-and-see approach before considering a long position.

TODAY'S FREE FLY STORIES

NOW

ServiceNow

$228.26

-12.315 (-5.12%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Hot Stocks
Breaking Hot Stocks news story on ServiceNow »

ServiceNow down 6.3% at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 09

    Dec

  • 12

    Dec

CALX

Calix

$7.15

0.005 (0.07%)

17:05
10/22/19
10/22
17:05
10/22/19
17:05
Earnings
Calix reports Q3 non-GAAP EPS 6c, consensus 4c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GSS

Golden Star Resources

$2.99

0.05 (1.70%)

17:04
10/22/19
10/22
17:04
10/22/19
17:04
Hot Stocks
Golden Star Resources to move corporate office, CFO Andre van Niekerk to leave »

Golden Star Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

TER

Teradyne

$59.24

-0.83 (-1.38%)

17:03
10/22/19
10/22
17:03
10/22/19
17:03
Earnings
Teradyne reports Q3 adjusted EPS 77c, consensus 70c »

Reports Q3 revenue $582M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 31

    Oct

UCBI

United Community Banks

$29.30

0.12 (0.41%)

17:02
10/22/19
10/22
17:02
10/22/19
17:02
Earnings
United Community Banks reports Q3 adjusted EPS 63c, consensus 58c »

On an operating basis,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

NEM

Newmont Goldcorp

$37.80

-0.17 (-0.45%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
Newmont Goldcorp starting production at Penasquito Mine in Mexico »

Newmont Goldcorp is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

ATR

AptarGroup

$116.78

-1.22 (-1.03%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
AptarGroup says Activ-Blister packaging solution approved by FDA »

AptarGroup announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

  • 12

    Nov

BUSE

First Busey

$25.45

0.05 (0.20%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Earnings
First Busey reports Q3 adjusted EPS 55c, consensus 52c »

For the third quarter of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

SNAP

Snap

$14.00

-0.58 (-3.98%)

17:01
10/22/19
10/22
17:01
10/22/19
17:01
Hot Stocks
Snap says each daily active user opens Snapchat 30 times per day on average »

Says community grew to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 21

    Nov

SMH

Market Vectors Semiconductor

$123.51

-0.88 (-0.71%)

, TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

16:57
10/22/19
10/22
16:57
10/22/19
16:57
Hot Stocks
Semiconductor stocks fall after Texas Instruments gives dismal outlook »

Shares of Market Vectors…

SMH

Market Vectors Semiconductor

$123.51

-0.88 (-0.71%)

TXN

Texas Instruments

$128.61

-2.32 (-1.77%)

INTC

Intel

$52.00

-0.12 (-0.23%)

QCOM

Qualcomm

$78.46

-0.5 (-0.63%)

TSM

TSMC

$50.66

0.65 (1.30%)

AVGO

Broadcom

$287.54

-2.03 (-0.70%)

NVDA

Nvidia

$195.52

-0.64 (-0.33%)

ASML

ASML

$255.32

-5.14 (-1.97%)

ADI

Analog Devices

$110.91

-0.18 (-0.16%)

LRCX

Lam Research

$234.91

-3.77 (-1.58%)

AMD

AMD

$31.51

-0.54 (-1.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 29

    Oct

  • 05

    Nov

  • 06

    Nov

  • 06

    Nov

  • 07

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

REED

Reed's

$0.70

-0.0297 (-4.07%)

16:51
10/22/19
10/22
16:51
10/22/19
16:51
Syndicate
Reed's announces common stock offering »

Reed's announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:45
10/22/19
10/22
16:45
10/22/19
16:45
Hot Stocks
Breaking Hot Stocks news story  »

PB Bancorp trading…

KRG

Kite Realty Group

$17.32

0.135 (0.79%)

16:42
10/22/19
10/22
16:42
10/22/19
16:42
Hot Stocks
Kite Realty Group completes disposition program 'fortifying' balance sheet »

Kite Realty Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

  • 12

    Nov

USO

United States Oil Fund

$11.35

0.145 (1.29%)

16:40
10/22/19
10/22
16:40
10/22/19
16:40
General News
API crude inventories for week of October 18 »

API reports that crude…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LRN

K12

$24.84

-0.56 (-2.20%)

16:37
10/22/19
10/22
16:37
10/22/19
16:37
Hot Stocks
K12 reports Q1 adjusted EBITDA $3.3M vs. $8.8M last year »

Reports Q1 Enrollment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

BIIB

Biogen

$281.89

58.32 (26.09%)

, PG

Procter & Gamble

$122.19

3.15 (2.65%)

16:36
10/22/19
10/22
16:36
10/22/19
16:36
On The Fly
Fly Intel: Wall Street's top stories for Tuesday »

The major averages ended…

BIIB

Biogen

$281.89

58.32 (26.09%)

PG

Procter & Gamble

$122.19

3.15 (2.65%)

UTX

United Technologies

$141.42

3.18 (2.30%)

MCD

McDonald's

$199.26

-10.585 (-5.04%)

TRV

Travelers

$130.22

-11.55 (-8.15%)

UPS

UPS

$116.10

-2.46 (-2.07%)

BA

Boeing

$337.45

6.33 (1.91%)

STMP

Stamps.com

$90.77

14.65 (19.25%)

LYFT

Lyft

$43.60

2.74 (6.71%)

SERV

ServiceMaster

$44.78

-11.295 (-20.14%)

HAS

Hasbro

$100.00

-20.11 (-16.74%)

NFLX

Netflix

$266.69

-11.3 (-4.06%)

VZ

Verizon

$60.80

0.06 (0.10%)

DIS

Disney

$132.44

2.16 (1.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 22

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

  • 26

    Oct

  • 29

    Oct

  • 30

    Oct

  • 05

    Nov

  • 07

    Nov

  • 07

    Nov

  • 07

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 09

    Dec

MTH

Meritage Homes

$74.88

0.23 (0.31%)

16:36
10/22/19
10/22
16:36
10/22/19
16:36
Earnings
Meritage Homes raises FY19 EPS view to $5.50-$5.70 from $5.20-$5.50 

Consensus $5.46.

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 19

    Nov

LRN

K12

$24.84

-0.56 (-2.20%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
K12 sees Q2 revenue $255M-$260M , consensus $255.93M »

Sees Q2 CapEx $9.0M-$11M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MTH

Meritage Homes

$74.88

0.23 (0.31%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
Meritage Homes reports Q3 EPS $1.79, consensus $1.50 »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 19

    Nov

LRN

K12

$24.84

-0.56 (-2.20%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Earnings
K12 sees FY20 revenue $1.02B-$1.035B , consensus $1.03B »

Sees FY20 capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

MGNX

MacroGenics

$11.01

-0.37 (-3.25%)

16:34
10/22/19
10/22
16:34
10/22/19
16:34
Hot Stocks
MacroGenics says first primary endpoint of PFS achieved in Phase 3 SOPHIA study »

MacroGenics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

, MSFT

Microsoft

$136.39

-2.05 (-1.48%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Hot Stocks
DoD's Esper removes himself from JEDI contract review, citing son's work »

Statement From Chief…

AMZN

Amazon.com

$1,766.07

-18.66 (-1.05%)

MSFT

Microsoft

$136.39

-2.05 (-1.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 29

    Oct

  • 06

    Nov

  • 21

    Nov

TRMK

Trustmark

$34.83

-0.15 (-0.43%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
Trustmark reports Q3 EPS 64c, consensus 62c »

Reports Q3 net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 13

    Nov

FULT

Fulton Financial

$16.76

0.09 (0.54%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
Fulton Financial reports Q3 EPS 37c, consensus 35c »

"Overall, we were…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

LRN

K12

$24.84

-0.56 (-2.20%)

16:32
10/22/19
10/22
16:32
10/22/19
16:32
Earnings
K12 reports Q1 EPS (25c), consensus (19c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.